← All trials
NCT05709184
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 31, 2023
- Primary completion
- Sep 30, 2024
- Completion date
- Mar 31, 2025
- First posted
- Feb 2, 2023
- Last posted
- Feb 24, 2023
- Enrollment
- 196
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Technion UniversityLead sponsor
- Lithuanian University of Health SciencesCollaborator
- University of MilanCollaborator
- University of AlbertaCollaborator
- University of DebrecenCollaborator
- Universita' Cattolica del Sacro CuoreCollaborator
- Technion UniversityReponsible party - principal investigator
- Imperial College LondonCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.